Secondary aplastic anemia Health Article

Licensed from Print
Table of Contents
Reviewer Info: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.; ADAM Health Illustrated Encyclopedia, 11/23/2008
Page: 1 2 Next >

Definition

Secondary aplastic anemia is a failure of the bone marrow to make enough blood cells. All blood cell types are affected.

Alternative Names

Anemia - secondary aplastic; Acquired aplastic anemia

Causes, incidence, and risk factors

Secondary aplastic anemia is caused by injury to blood stem cells. Normal blood stem cells divide and turn into all blood cell types, mainly white blood cells, red blood cells, and platelets. When blood stem cells are injured, there is a reduction in all blood cell types.

This condition can be caused by:

When the cause is unknown, it is referred to as idiopathic aplastic anemia. In about half of all cases, no cause can be found.

The disease may be acute or chronic.

Symptoms

  • Bleeding of the gums
  • Bleeding of internal organs
  • Easy bruising
  • Fatigue
  • Frequent or severe infections
  • Nosebleeds
  • Rapid heart rate
  • Rash
  • Shortness of breath during physical activity
  • Weakness

Signs and tests

Signs include:

Tests may include:

Treatment

In secondary aplastic anemia, removing the cause is critical. In some cases it can lead to recovery.

Mild cases of aplastic anemia may be treated with supportive care, or may not need treatment. Blood and platelet transfusions will help correct the abnormal blood counts and relieve some symptoms in moderate cases.

Severe aplastic anemia, which causes a very low blood-cell count, is a life-threatening condition. Younger patients with a severe case of the disease will need a bone marrow transplant. Older patients, or those who do not have a matched bone marrow donor, can be treated with medications that suppress the immune system, such as antithymocyte globulin (ATG), tacrolimus, or cyclosporine.

ATG consists of antibodies made in horses or rabbits against a type of white blood cell in humans called T cells. It is used to suppress the body's immune system, allowing the bone marrow to start generating blood cells again. Other medications to suppress the immune system, such as cyclosporine, tacrolimus, and cyclophosphamide (Cytoxan) also may be used. Corticosteroids and androgens have been used as well.

Page: 1 2 Next >

advertisement

Back to Top Print

Use of this Web site constitutes acceptance of our Terms and Conditions of Use and Privacy Policy.